Hepatitis Education

HBV and HCV are silent killers!

You can save your life by screening for HBV/HCV.  If you are HBV or HCV carrier, monitor your liver condition regularly and get early treatment.

Help saving your friends' lives by educating your friends about the deadly consequence of chronic hepatitis.

Alarming Facts

Worldwide, nearly 500 million persons are living with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections, and these infections cause approximately 1 million deaths annually. In the U.S. an estimated 3.5-5.3 million persons are living with viral hepatitis, and millions more are at risk for infection. Because viral hepatitis can persist for decades without symptoms, 65%-75% of infected Americans remain unaware of their infection status and are not receiving care and treatment. Without timely care, 1 in 4 persons with chronic hepatitis will develop liver cirrhosis or liver cancer

HBV:
Every year, approximately 3,000 people in the United States and more than 600,000 people worldwide die from Hepatitis B-related liver disease. In fact, 80 percent of liver cancer worldwide is caused by Hepatitis B infection.
1 in 10 Asian-Americans is chronically infected with Hepatitis B.

HCV:
Estimated 170 million people infected worldwide, three to four million people newly infected each year.
An estimated 3.2 million Americans have Hepatitis C. Approximately 12,000 people die every year from Hepatitis C-related liver disease.
Hepatitis C is almost twice as common among African Americans as among whites.

Europe:
About one-quarter of the liver transplants performed in 25 European countries in 2004 were attributable to HCV. HCV puts a significant burden on patients and society. Estimations indicate that HCV caused more than 86,000 deaths and 1.2 million disability-adjusted life-years (DALYs) in the WHO European region in 2002. Most of the DALYs (95%) were accumulated by patients in preventable disease stages.

Hepatitis ABC Fact Sheet for Professionals

Who needs screening and treatment?

CDC information for Hepatitis B, Hepatitis C

HBV:
Hepatitis B is diagnosed with specific blood tests that are not part of blood work typically done during regular physical exams. Those living with chronic Hepatitis B should be evaluated for liver problems and monitored on a regular basis. Even though a person may not have symptoms or feel sick, damage to the liver can still occur. Several new treatments are available that can significantly improve health and delay or reverse the effects of liver disease.

The best way to prevent Hepatitis B is by getting vaccinated. For adults, the Hepatitis B vaccine is given as a series of three shots over a period of six months. The entire series is needed for long-term protection. Booster doses are not currently recommended.

Interpretation of Hepatitis B Serologic Test Results

Screening Asian Patients for Chronic Hepatitis B
For Asian individual, should Screen for Chronic Hepatitis B (recommended by CDC). Reasons:
High risk - 1 in every 12 Asian Americans is living with chronic hepatitis B. Approximately 1.2 million people in the US are living with chronic hepatitis B.
Deadly outcome - If undiagnosed and untreated, up to 25% of infected persons will develop serious complications, including hepatocellular carcinoma and decompensated cirrhosis.

HCV:
Doctors can diagnose Hepatitis C using specific blood tests that are not part of blood work typically done during regular physical exams. People with chronic Hepatitis C should be monitored regularly for signs of liver disease. Even though a person may not have symptoms or feel sick, damage to the liver can still occur. Antiviral medication can be used to treat some people with chronic Hepatitis C, although not everyone needs or can benefit from treatment. For many, treatment can be successful and results in the virus no longer being detected.

Hepatitis C Screening & Medical Management

National efforts to stop the silent killers

Presidential Proclamation--World Hepatitis Day:
BY THE PRESIDENT OF THE UNITED STATES OF AMERICA
Across our Nation, millions of Americans are living with viral hepatitis. As many as three-fourths of Americans living with the disease are unaware of their status and are not receiving care and treatment for their condition. Raising awareness about hepatitis is crucial to effectively fight stigmas, stem the tide of new infections, and ensure treatment reaches those who need it.

US HHS:

CDC Viral Hepatitis website: information for patients and professionals.

IOM report:

National Viral Hepatitis Roundtable (NVHR): world hep day rally video

Viral Hepatitis Action Coalition: Hepatitis B, Hepatitis C

Hepatitis C video on Discovery channel

Global efforts to eliminate hepatitis virus

WHO World Hepatitis Day:
The World Health Organization (WHO) has declared Thursday, July 28, as World Hepatitis Day. World Hepatitis Day is an annual event that each year provides an international focus for patient groups and people living with hepatitis. It provides an opportunity to focus on specific actions such as:
  • strengthening prevention, screening and control of viral hepatitis and its related diseases;
  • increasing hepatitis B vaccine coverage and integration into national immunization programs; and
  • coordinating a global response to hepatitis.
World Hepatitis Alliance:
As a coalition of advocacy groups, the World Hepatitis Alliance is a global voice for the 500 million people worldwide living with chronic viral hepatitis B or C.

Hepatitis C drugs:

Genotype 1 of the disease is the most difficult to treat and takes the longest.
  • Victrelis from Merck
  • Incivek from Vertex Pharmaceuticals
  • INCIVO (Telaprevir) from Johnson & Johnson
Genotypes 2 and 3 are responsive to a drug combination of Peg-Interferon and Ribavirin and are easily cured in a short period of time.

Comments